How to Choose an Addiction Treatment Program

Why it matters which program you choose

Addiction treatment is not a commodity. The clinical quality, ethical practices, and fit of a program all affect whether treatment actually works for a specific person. Programs that are poorly licensed, that use predatory business practices, or that offer a one-size-fits-all approach to a condition that requires individualized care can waste valuable time and money. In the worst cases, they cause active harm.

The stakes are high. When someone decides they are ready for treatment, that window of readiness is real and finite. Getting into a program that lacks clinical integrity or is structurally mismatched to the person's actual need can result in early dropout, a return to use, and a harder time trusting treatment the next time. Choosing well matters.

This guide is designed to give you the framework to evaluate treatment programs as a clinical consumer, not a desperate buyer. Most of the information here is knowable in a single phone call and a review of publicly available licensing and accreditation records. You do not need to be a clinician to ask the right questions. You need to know what to ask.

Licensing and accreditation: what to look for and how to verify

Every addiction treatment program operating in New Jersey must be licensed by the New Jersey Division of Mental Health and Addiction Services (DMHAS) for each level of care it provides. Licensing is not optional, and the license type should match the services being offered. A program that offers PHP should have a PHP license. A program that offers medically supervised detox should have the appropriate license for that level. Ask to see the license, ask for the license number, and verify it at the New Jersey Division of Consumer Affairs provider verification portal or by calling the DMHAS office.

Accreditation is separate from licensing and goes further. The two major accrediting bodies for behavioral health programs are The Joint Commission (TJC) and the Commission on Accreditation of Rehabilitation Facilities (CARF). Accreditation from either organization means that the program has undergone a rigorous external review of its clinical standards, staff qualifications, facility standards, and patient care practices. Most commercial insurance carriers and Medicaid programs require accreditation as a condition for credentialing a program in their network.

LegitScript certification is a third-party verification relevant specifically to online marketing practices. Programs with LegitScript certification have been reviewed to confirm they are legitimately operating, not engaging in deceptive or illegal advertising. While not a clinical quality marker, it is a basic trust signal.

Licensing and accreditation together give you a foundation. They do not guarantee a good experience or perfect outcomes, but their absence is a serious red flag that should end the conversation.

• NJ DMHAS license: required for every level of care, verifiable at the NJ Division of Consumer Affairs
• Joint Commission or CARF accreditation: the gold standard for clinical program quality; required by most major insurers for network credentialing
• LegitScript certification: a basic legitimacy check on the program's marketing and business practices
• Ask for the license number and verify it independently; do not rely solely on the program's own claim
• Check for any disciplinary actions or license restrictions on the DMHAS or Division of Consumer Affairs records

ASAM criteria and level-of-care matching: the clinical standard

The American Society of Addiction Medicine (ASAM) Criteria is the nationally recognized clinical framework for determining the appropriate level of addiction care. A legitimate treatment program uses the ASAM framework, or a comparable evidence-based placement tool, to assess each client across six dimensions and match them to the right level of care. The six dimensions cover withdrawal risk, medical complications, mental health status, readiness to change, relapse risk, and living environment.

Ask any program you are evaluating: how do you determine which level of care is appropriate for a new client? The answer should reference the ASAM Criteria or a comparable structured clinical assessment tool. If the answer is that everyone starts in the same program regardless of clinical presentation, that is a red flag. Effective treatment begins with an honest assessment of where a person actually is, not a blanket placement decision driven by what the program has available.

ASAM criteria also govern ongoing level-of-care decisions. As a client progresses, the clinical picture changes and the appropriate level of care may change with it. A program that has a rigid, locked-in path for all clients, with no mechanism to step up to more intensive care when someone struggles or step down when they stabilize, is not practicing individualized care. Ask how the program handles step-ups and step-downs.

Evidence-based therapies: what they are and why they matter

Evidence-based treatment refers to therapeutic approaches that have been studied in rigorous clinical trials and shown to be effective for substance use disorders. The major evidence-based modalities for addiction treatment include cognitive-behavioral therapy (CBT), motivational interviewing (MI), dialectical behavior therapy (DBT), medication-assisted treatment (MAT) for opioid and alcohol use disorder, and contingency management. Trauma-informed care is also a recognized evidence-based framework for the significant proportion of people with addiction who have co-occurring trauma histories.

Ask any program you are evaluating: what therapies are used in your programming? A credible answer names specific evidence-based modalities. If the answer is vague, proprietary, or involves primarily non-evidence-based approaches such as unstructured confrontation therapy, sweat lodges as primary treatment, or reliance on a single non-peer-reviewed model, those are concerns.

Evidence-based does not mean a program cannot have a spiritual or faith-based orientation. Programs can integrate faith traditions alongside evidence-based clinical work. What matters is that the clinical foundation is grounded in approaches the research supports, not just the founder's personal philosophy.

• Cognitive-behavioral therapy (CBT): addresses patterns of thought and behavior that contribute to substance use
• Motivational interviewing (MI): a collaborative approach to building and strengthening motivation for change
• Dialectical behavior therapy (DBT): particularly useful for clients with emotional regulation challenges or trauma histories
• Medication-assisted treatment (MAT): FDA-approved medications (buprenorphine, naltrexone, methadone) for opioid and alcohol use disorder; not a standalone treatment but a component of comprehensive care
• Contingency management: structured reinforcement of abstinence and treatment engagement; strong evidence base for stimulant and alcohol use disorders
• Trauma-informed care: a framework recognizing the high prevalence of trauma among people with addiction and adjusting clinical approaches accordingly

Insurance, cost, and financial transparency

A reputable treatment program should be able to tell you, before you commit to anything, what your insurance covers, what your out-of-pocket responsibility is, and what happens if coverage runs out before treatment is clinically complete. Vagueness about costs and billing practices is a yellow flag. A program that cannot give you clear information about billing until after you arrive is not operating with appropriate financial transparency.

Ask whether the program accepts your specific insurance plan and whether they are in-network or out-of-network. In-network status generally means lower out-of-pocket costs, but out-of-network can sometimes be appropriate if a single-case agreement is possible. Ask what your deductible exposure is and when it resets. Ask whether there are any services, such as medication management, lab work, or psychiatric evaluation, that are billed separately and not included in the program fee.

Federal parity law (the Mental Health Parity and Addiction Equity Act) requires that insurers cover substance use disorder treatment at parity with medical and surgical benefits. If a program tells you that insurance will not cover any of their treatment, or that their program is entirely self-pay by design, ask why and verify the claim independently. Most accredited outpatient programs in New Jersey accept major commercial insurance and NJ FamilyCare (Medicaid).

Red flags: patient brokering, guarantees, and high-pressure tactics

Patient brokering is illegal in New Jersey and at the federal level. It refers to the practice of paying or receiving fees for patient referrals, which creates financial incentives that corrupt clinical decision-making and direct people to the wrong program for the wrong reasons. If a program paid for a referral from a recovery coach, a call center, or a website that screened you and connected you with a specific facility, ask how that referral was made and whether any fees changed hands. Legitimate programs do not pay for referrals.

Programs that guarantee specific outcomes, guarantee sobriety, or claim unusually high success rates without transparent disclosure of how those figures are calculated are making claims they cannot support. Addiction treatment involves a complex, chronic condition. Honest programs discuss realistic expectations, not promises.

High-pressure sales tactics in the admissions process, insistence on a commitment before insurance is verified, demands for upfront cash payment before any clinical contact, or discouraging you from speaking with other programs or asking questions are all red flags. The admissions process at a reputable program is informative and honest, not coercive.

• Patient brokering: illegal referral fee arrangements that direct clients to programs for financial rather than clinical reasons
• Guaranteed outcomes: no program can ethically guarantee sobriety; programs that do are making false promises
• Pressure to commit before insurance verification: any program worth attending will verify your benefits before asking for a decision
• Discouraging questions or comparisons: a confident program welcomes clinical scrutiny; one that resists it has something to hide
• Upfront cash payment demands before assessment: not a standard practice at legitimate outpatient programs

Questions to ask on the initial call

A single well-prepared phone call to an admissions specialist reveals most of what you need to know about a program's integrity and clinical approach. The following questions are direct, professional, and appropriate to ask.

• What is your NJ DMHAS license number, and what levels of care are you licensed to provide?
• Are you accredited by The Joint Commission or CARF, and can you provide your accreditation number?
• What clinical assessment tool do you use to determine the appropriate level of care, and do you use ASAM Criteria?
• What evidence-based therapies are used in your PHP and IOP programs?
• Do you accept my specific insurance plan, and can you provide a benefits verification before I commit?
• What co-occurring mental health conditions do you treat alongside addiction?
• How do you handle step-ups and step-downs between levels of care if my clinical needs change?
• Is your program willing to coordinate with my current prescribers or primary care provider?
• How are referrals made to your program, and does your program pay referral fees for patient placements?
• What does aftercare planning look like, and when does that process begin?